GAMA
GH icon

Graticule Asia Macro Advisors’s Guardant Health GH Stock Holding History

Graticule Asia Macro Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.2K Buy
+481
New +$52.3K 0.01% 118
2021
Q3 		– Sell
-16,000
Closed -$1.99M – 131
2021
Q2 		$1.99M Sell
16,000
-73,380
-82% -$9.87M 0.59% 47
2021
Q1 		$13.6M Buy
+89,380
New +$13.5M 2.27% 9

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Graticule Asia Macro Advisors's GH Position: Q2 2026 in Review

Graticule Asia Macro Advisors opened a new position in Guardant Health (GH) in Q2 2026: 481 shares worth $72.2K. The stake represents 0.01% of the portfolio and ranks #118 among its holdings. This is a return to the name: Graticule Asia Macro Advisors previously reported a position in GH as recently as Q2 2021.

Graticule Asia Macro Advisors first reported a position in GH in Q1 2021 and has held it in 3 quarters since. The position peaked at $13.6M in Q1 2021. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Graticule Asia Macro Advisors held 481 shares of Guardant Health worth $72.2K as of Q2 2026.
  • Guardant Health was a new Graticule Asia Macro Advisors position in Q2 2026.
  • Guardant Health made up 0.01% of Graticule Asia Macro Advisors's portfolio in Q2 2026, its #118 holding.
  • Graticule Asia Macro Advisors first reported a position in Guardant Health in Q1 2021 and has held it in 3 quarters since.
  • Graticule Asia Macro Advisors's Guardant Health position peaked at $13.6M in Q1 2021.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.